ASKG915 — Investigational Agent
Antibody-Drug Conjugate · Phase 1/2 · AskGene Pharma
Mechanism of Action
An antibody-drug conjugate delivering a cytotoxic payload to antigen-expressing tumor cells, evaluated as monotherapy and in combination with chemotherapy and antiangiogenic agents across selected advanced solid tumors.
Investigational Indications
- Advanced solid tumors
- Gynecologic malignancies
- Gastrointestinal tumors